BARBARA BALL: Open Payments
NPI 1538233390 · HAMPSTEAD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 62 payments from 15 companies in 2025. Trend: 2023 $314 · 2024 $1,024 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $227 |
| PFIZER INC. | 10 | $205 |
| AstraZeneca Pharmaceuticals LP | 7 | $141 |
| Axsome Therapeutics, Inc. | 4 | $102 |
| Lilly USA, LLC | 5 | $93 |
| Novo Nordisk Inc | 4 | $89 |
| Collegium Pharmaceutical, Inc. | 4 | $84 |
| Amgen Inc. | 4 | $65 |
| Exact Sciences Corporation | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
Products named: NURTEC ODT, Auvelity, VRAYLAR, QULIPTA, MOUNJARO, Ozempic, Jornay PM, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
